Key result
SLC3A2 silencing delays lethal aortic rupture and curbs medial degeneration in experimental aortic dissection.
Why the study?
Disulfidptosis, a novel disulfide stress-induced cell death, remained unexplored in aortic dissection, and whether the disulfidptosis-related gene SLC3A2 contributes to aortic dissection pathogenesis was unknown.
Does SLC3A2 silencing alleviate aortic dissection progression by activating cAMP-PKA signaling and inhibiting disulfidptosis in preclinical models?
Does SLC3A2 silencing alleviate aortic dissection progression by activating cAMP-PKA signaling and inhibiting disulfidptosis in preclinical models?
Identifies disulfidptosis and the SLC3A2/cAMP-PKA signaling axis as drivers of aortic dissection pathogenesis and potential therapeutic targets in preclinical models.
Answers are grounded in this paper and cite their sources.
May support SLC3A2 as a target in aortic dissection; hypothesis-generating in animal models and leaves clinical translation open.
Aortic dissection (AD) is a life‐threatening cardiovascular emergency. Disulfidptosis, a novel disulfide stress‐induced cell death, remains unexplored in AD. We investigated whether solute carrier family 3 member 2 (SLC3A2), a disulfidptosis‐related gene, contributes to AD pathogenesis. Bioinformatic analyses of Gene Expression Omnibus datasets combined machine learning algorithms to identify SLC3A2 as a core gene. A murine AD model was established using β‐aminopropionitrile and angiotensin II, with lentiviral knockdown of SLC3A2. Human aortic vascular smooth muscle cells (HAVSMCs) were challenged with BAY‐876 to induce disulfidptosis. Histological staining evaluated medial degeneration and elastic fiber integrity. Disulfidptosis was assessed by measuring cystine accumulation and the protein expression of filamin A (FLNA) and NCK‐associated protein 1 (NCKAP1). The involvement of cyclic adenosine monophosphate (cAMP)‐protein kinase A (PKA) signaling was verified by genetic knockdown of its catalytic subunit (PRKACA). We observed SLC3A2 was upregulated in AD. SLC3A2 knockdown delayed lethal aortic rupture, reduced aortic medial degeneration, decreased reactive oxygen species and cystine, while restoring glutathione and free thiols. In HAVSMCs, SLC3A2 silencing preserved filamentous actin integrity, reversed the BAY‐876‐induced downregulation of α‐smooth muscle actin and smooth muscle 22 alpha, and restored the aberrant expression of FLNA and NCKAP1. Mechanistically, SLC3A2 knockdown reactivated the cAMP‐PKA signaling axis suppressed by BAY‐876, and PRKACA knockdown abrogated the protective effects of SLC3A2 silencing on oxidative stress, cytoskeletal integrity, and disulfidptosis. In conclusion, SLC3A2 drives AD progression by suppressing cAMP‐PKA signaling, thereby exacerbating oxidative stress and disulfidptotic cytoskeletal collapse. Targeting the SLC3A2/cAMP‐PKA axis represents a promising therapeutic strategy for AD.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied Aortic dissection. Lentiviral knockdown / silencing of SLC3A2 vs. Control / PRKACA genetic knockdown was evaluated on Lethal aortic rupture, aortic medial degeneration, elastic fiber integrity, and disulfidptosis markers (cystine accumulation, FLNA, and NCKAP1 expression). SLC3A2 silencing delayed lethal aortic rupture, reduced aortic medial degeneration, and inhibited disulfidptosis by reactivating the cAMP-PKA signaling axis in experimental aortic dissection models.
Synapse has enriched 10 related papers. Consider them for comparative context: